MedPath

SEVOFLURANE

SEVOFLURANE

Approved
DIN Number

02265974

Drug Class

Human

Market Date

Apr 11, 2007

Company
HC

baxter corporation

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02265974
AIG Number0127780001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N01AB08 SEVOFLURANE
Product Specifications
Dosage FormLiquid
Route of AdministrationInhalation
AHFS Classification28:04.16
Health Canada Classification

ACTIVE INGREDIENTS (1)

SEVOFLURANEActive
Strength: 99.97 %
Monograph: SEVOFLURANE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.